	a_count	a_term	ab_count	ab_pmid_intersection	ab_pred_score	ab_pvalue	ab_sort_ratio	b_count	b_term	total_count	ab_hypothesis
0	989	warfarin&drug&interaction	52	[15911722, 7944078, 24550106, 20002088, 25646891, 11510629, 25929560, 18673195, 20881954, 9740537]	0.3308127940737864	2.689687786375712e-101	0.0057694441362476	9013	omeprazole	36618932	omeprazole may effectively alleviate or target key pathogenic mechanisms of warfarin, potentially offering therapeutic benefits or slowing disease progression.
1	989	warfarin&drug&interaction	42	[10709776, 12036392, 15871634, 15568889, 15260917, 15676159, 16477470, 22339447, 26041408, 14998226]	0.2430543585918116	5.57790815186769e-75	0.0039095224797542	10743	simvastatin	36618932	simvastatin may effectively alleviate or target key pathogenic mechanisms of warfarin, potentially offering therapeutic benefits or slowing disease progression.
2	989	warfarin&drug&interaction	26	[7944078, 10709776, 9512916, 8801057, 18685566, 21142266, 8801058, 15963007, 15654717, 11523726]	0.1218219725659474	3.8424567580901135e-38	0.0017788724685276	14616	fluconazole	36618932	fluconazole may effectively alleviate or target key pathogenic mechanisms of warfarin, potentially offering therapeutic benefits or slowing disease progression.
3	989	warfarin&drug&interaction	16	[25646891, 7429002, 3395358, 9667024, 20489028, 22987806, 28287743, 24741184, 18937368, 24699894]	0.0687992038776355	1.3501383941522289e-21	0.001244942421413	12852	furosemide	36618932	furosemide may effectively alleviate or target key pathogenic mechanisms of warfarin, potentially offering therapeutic benefits or slowing disease progression.
4	989	warfarin&drug&interaction	8	[10709776, 20002088, 6096071, 8793611, 8793602, 29498038, 25573019, 33777573]	0.0347929189305711	7.571592140369909e-11	0.0010285420416559	7778	metoprolol	36618932	metoprolol may effectively alleviate or target key pathogenic mechanisms of warfarin, potentially offering therapeutic benefits or slowing disease progression.
5	989	warfarin&drug&interaction	4	[22250655, 22406649, 32862668, 34691471]	0.0173861052724603	1.583282174785851e-05	0.0007506098705197	5329	enoxaparin	36618932	enoxaparin may effectively alleviate or target key pathogenic mechanisms of warfarin, potentially offering therapeutic benefits or slowing disease progression.
6	989	warfarin&drug&interaction	3	[22794158, 32982467, 34691471]	0.0075385443132446	0.0063586949947517	0.0002194747238276	13669	ceftriaxone	36618932	ceftriaxone may effectively alleviate or target key pathogenic mechanisms of warfarin, potentially offering therapeutic benefits or slowing disease progression.
7	989	warfarin&drug&interaction	16	[8792056, 16697485, 21053990, 21253716, 11248285, 28263937, 11085346, 17378769, 21990651, 31326559]	0.0272456691782747	2.550024903198377e-09	0.0001905397037107	83972	heparin	36618932	heparin may effectively alleviate or target key pathogenic mechanisms of warfarin, potentially offering therapeutic benefits or slowing disease progression.
